Roles of pharmacotherapy and dietotherapy in type II diabetes mellitus

A tétel rövid nézete
dc.contributor.advisorGyöngyösi, Alexandra
dc.contributor.advisordeptDebreceni Egyetem::Gyógyszerésztudományi Karhu_HU
dc.contributor.advisordeptPharmacology departmenthu_HU
dc.contributor.authorNiaparast, Rashin
dc.contributor.departmentDE--Gyógyszerésztudományi Karhu_HU
dc.contributor.opponentHerczeg, Mihàly
dc.contributor.opponentVasvári, Gábor
dc.contributor.opponentdeptDebreceni Egyetem::Gyógyszerésztudományi Karhu_HU
dc.date.accessioned2021-04-26T07:24:45Z
dc.date.available2021-04-26T07:24:45Z
dc.date.created2021-04-23
dc.description.abstractDiabetes is metabolic disease, results increased blood glucose level, which is increasing in past 10 years among the population, especially in western countries. Type II diabetes mellitus or non insulin dependent diabetes. It has a direct connection with lifestyle and diet, it will be caused due to insulin resistance and in combined with decrease amount of insulin production. First line of pharmaceutical therapy in T2DM is oral anti diabetic treatment, which are driven into five groups: Biguanides, Sulfonylureas, Dipeptidyl peptidase 4 (DPP4) inhibitors, Glucagon like peptide 1 (GLP 1) analogues, Sodium glucose co transporter 2 (SGLT2) inhibitors. Insulin therapy can be used in the last stage in conventional and intensive form. Diet and lifestyle play an important role in treatment of T2DM.hu_HU
dc.description.coursegyógyszerészhu_HU
dc.description.courselangangolhu_HU
dc.description.coursespecOrvosbiológia-farmakológiahu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent29hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/307394
dc.language.isoenhu_HU
dc.subjectType II diabetes mellitushu_HU
dc.subjectPharmacotherapyhu_HU
dc.subjectDiethu_HU
dc.subjectLifestylehu_HU
dc.subject.dspacePharmacologyhu_HU
dc.titleRoles of pharmacotherapy and dietotherapy in type II diabetes mellitushu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Pharmacy)